Risk progression after HMA worsens post-alloHSCT outcomes, whereas risk improvement does not confer a survival benefit. Read the full study in Blood Advances: https://t.co/WzKyxnvqex
Landmark Paper: in 2002 Silverman et al. published results of the phase III CALGB 9221 trial, showing how azacitidine not only caused sustained improvement in cytopenias but also altered the course of myelodysplastic syndromes.
https://t.co/gVMJCmSDYW
Excellent discussions at the 4th annual i4MDS meeting in Milan — advancing immunobiology insights and moving closer to smarter stratification and better treatments for MDS.
#i4MDS#EHA#MDS#Hematology#Immunology
If you are interested in how to use molecular information for treatment response in LR-MDS, here I discuss our recent work. Check it out! https://t.co/LhFIs6K9U6 via @vumedi
It’s finally out! Big thanks to all the collaborators who joined this project which will hopefully open the doors to a more personalized medicine for patients with LR-MDS based on gender and genetic profile.
A special thank to my mentor @Santin13Valeria
https://t.co/N2pEY6AaD8
Plenary session on low risk MDS treatment from MDS foundation congress. As last speaker I will share some data from our group @Santin13Valeria uncovering “dark” aspects of ring sideroblasts presence in MDS with low blasts count!
https://t.co/WNMnHllynE
Want a comprehensive overview of the current treatment options for patients with lower-risk MDS and anemia?🩸
Then don't forget to check out our fantastic interview with @Santin13Valeria (@UNI_FIRENZE) from #EHA2025!😄
Watch here:
🎥 https://t.co/1CnTDjnxmW
#MDSsm#HemOnc
It’s finally out in Blood!!
A new molecular scoring system improving ESA response prediction in LR-MDS (ESA-PSS-M).
Check it out! Thanks to all the collaborators
#precisionmedicine#MDS
https://t.co/azzYqru0sI
It’s out! Honored to have contributed with my mentor to this comprehensive and practical review on newly approved treatments for LR-MDS!
American Society of Clinical Oncology Educational Book https://t.co/tpZNt2wgE9
Hope to see you tomorrow at #MDS2025 in the beautiful #Rotterdam! An unique opportunity to explore the forefront of Myelodysplastic Syndromes! If you have intereset in MDS-RS biology
and clinical correlations, join the session below!
"https://t.co/NiIKU9O1S2".
It’s such a great honor that my work has been awarded the second prize for clinical research at #U40inhematology
It was such a pleasure to join this project and see young colleagues and friends from every part of Italy to present and discuss research in hematology.
In past 2 days, we had our annual #i4MDS meeting in The Hague. Great discussions with colleagues about the role of the immune system in MDS and novel findings. Three years ago, when we founded this group, I never expected this level of progress and collaboration. Truly delighted.